Terns Pharmaceuticals Appoints Emil Kuriakose, M.D., as
Experienced Leader Brings Extensive Clinical Development and Medical Affairs Expertise in Oncology...
Source: globenewswire.com
Page 9 - Nasdaq Tern News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nasdaq Tern Today - Breaking & Trending Today
Terns Announces Pricing of $75 Million Public Offering
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Source: globenewswire.com
Terns Pharmaceuticals Reports Second Quarter 2022 Financial
TERN-701 (allosteric BCR-ABL inhibitor) advances into Phase 1 trial for CML in ChinaIND-enabling activities for TERN-601 (GLP-1R agonist) remain on track;...
Source: globenewswire.com
Terns Pharmaceuticals (NASDAQ:TERN) Rating Lowered to Sell at Zacks Investment Research
Zacks Investment Research downgraded shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Thursday morning, Zacks.com reports. According to Zacks, “Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It engages in development of small-molecule single-agent and combination therapy candidates for […]
Source: etfdailynews.com